0HG8.LSE Elevance Health

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
16.3x
P/B
-
ROE
13.7%
Dividend yield
0.01%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 0HG8.LSE undervalued?

Graham number

The Graham number of Elevance Health cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Elevance Health fundamental analysis

No fundamental analysis for Elevance Health yet.

Elevance Health stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Elevance Health

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and othe…

Full company profile